Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-04-07 | Patrick J. Scannon, M.D., Ph.D. has served as a director since 2007. ... The Audit Committee consists of directors Dr. Gussin, Dr. Scannon and Mr. Robertson, each of whom the Board of Directors of the Company has determined is independent as defined under the NASDAQ Stock Market LLC. listing standards as well as the SEC rules. ... The following table sets forth all non-employee director compensation for the year ended December 31, 2007. ... Patrick J. Scannon, M.D., Ph.D. 6,365 6,365 |
| 2009-04-06 | Patrick J. Scannon, M.D., Ph.D. (1)(3) 61 Class III Director ...The Audit Committee consists of directors Dr. Gussin, Dr. Scannon and Mr. Robertson... ...DIRECTOR COMPENSATION ... Patrick J. Scannon, M.D., Ph.D. Option Awards($) 92,294 Total($) 92,294 |
| 2010-04-07 | Patrick J. Scannon, M.D., Ph.D. (1)(3) 62 Class III Director (1) Member of Audit Committee. The Audit Committee consists of directors Dr. Gussin, Mr. Robertson and Dr. Scannon. Director Compensation Table: Patrick J. Scannon, M.D., Ph.D. Option Awards ($): 87,936 Total ($): 87,936 |
| 2011-04-08 | The Audit Committee consists of directors Dr. Gussin, Mr. Robertson and Dr. Scannon... Director Compensation Patrick J. Scannon, M.D., Ph.D. Option Awards($): 186,726 Total($): 186,726 |
| 2012-04-04 | Patrick J. Scannon, M.D., Ph.D. 152,483 ... The Audit Committee consists of directors Dr. Gussin, Mr. Robertson and Dr. Scannon ... |
| 2013-04-05 | Director Compensation Patrick J. Scannon, M.D., Ph.D. Option Awards: $102,111 Total: $102,111 Audit Committee member |
| 2014-04-07 | Patrick J. Scannon, M.D., Ph.D. (3) 66 Class III Director Director Compensation The following table sets forth all director compensation for 2013for all directors who are not named executive officers. Option Awards ($) Total($) Patrick J. Scannon, M.D., Ph.D. 111,250 111,250 |
| 2015-04-07 | Patrick J. Scannon, M.D., Ph.D. (3) 67 Class III Director (3) Meets the definition of independence under the NASDAQ Stock Market LLC listing standards. (1) Member of Audit Committee. Director Compensation The following table sets forth all director compensation for 2014for all directors who are not named executive officers. Option Awards ($) Total($) Patrick J. Scannon, M.D., Ph.D. 118,472 118,472 |
| 2016-04-14 | Patrick J. Scannon, M.D., Ph.D. 125,780 The Audit Committee consists of directors Dr. Gussin, Mr. Robertson and Ms. Ramasastry. |
| 2017-03-21 | Patrick J. Scannon, M.D., Ph.D. has served as a director since 2007. ... Patrick J. Scannon, M.D., Ph.D. 69 Class III Director ... The following table sets forth all director compensation for 2016 for all directors who are not named executive officers. ... Patrick J. Scannon, M.D., Ph.D. 118,034 118,034 |
| 2018-03-27 | Patrick J. Scannon, M.D., Ph.D. has served as a director since 2007. ... Patrick J. Scannon, M.D., Ph.D. 70 Class III Director ... The Audit Committee consists of directors Dr. Gussin, Mr. Robertson and Ms. Ramasastry. ... The following table sets forth all director compensation for 2017 for all directors who are not named executive officers. ... Patrick J. Scannon, M.D., Ph.D. 107,477 107,477 |
| 2019-03-29 | Patrick J. Scannon, M.D., Ph.D. (3) 71 Class III Director (3) Meets the definition of independence under the Nasdaq Stock Market LLC listing standards. Director Compensation Patrick J. Scannon, M.D., Ph.D. 8,107 8,107 |
| 2020-03-26 | Patrick J. Scannon, M.D., Ph.D. has served as a director since December 2007. |
| 2021-03-31 | Patrick J. Scannon, M.D., Ph.D., 73, Class III Director. Member of Audit Committee. Director compensation for 2020 was $37,962. |
| 2022-03-24 | Patrick J. Scannon, M.D., Ph.D. (4) 74 Class III Director ... (4) Meets the definition of independence under the Nasdaq Stock Market LLC listing standards. |
| 2023-03-27 | Patrick J. Scannon, M.D., Ph.D., 75, Class III Director. No compensation awarded in 2022 to directors who are not named executive officers. |
| 2024-03-26 | Patrick J. Scannon, M.D., Ph.D. 76 Class III Director ... Director Compensation Table shows total compensation of $438,424 for Mr. Scannon in 2023. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-06-09 | Patrick J. Scannon, M.D., Ph.D. Executive Vice President, Chief Medical Officer and Director |
| 2011-04-20 | Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011. |
| 2012-04-11 | Patrick J. Scannon, M.D. Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011. ... Dr. Scannon (Executive Vice President and Chief Scientific Officer) is not listed in the director compensation table because he received no additional compensation for services as a member of the Board or its committees. ... Summary Compensation Table shows total compensation of $919,738 for 2011. |
| 2013-04-11 | Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011. |
| 2014-04-11 | Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011. |
| 2015-04-10 | Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011. |
| 2016-04-08 | Patrick J. Scannon, M.D., Ph.D. is one of the Company’s founders and has served as a director since its formation. Dr. Scannon became Executive Vice President and Chief Scientific Officer in February of 2011. |
| 2016-09-12 | Patrick J. Scannon, M.D., Ph.D. is listed as a director with beneficial ownership in the proxy statement on pages 13-14. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22